Stock & Company Details
BioAtla Inc $BCAB
Price:
46,691,331
$6.1M
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
0.00
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
BCAB technical indicators
Latest BioAtla Inc (BCAB) technical indicators as of 2026-07-21: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
46.30 0.4%
MACD:
0.02 49.2%
SMA 50:
$3.85 0.3%
SMA 200:
$1.85 0.8%
EMA 20:
$3.88 0.5%
Bollinger Bands:
4.43 / 3.39
Stochastic:
22.76 27.1%
ADX 14:
24.24 3.0%
ATR 14:
0.37 2.9%
CCI 20:
-63.88 49.0%
OBV:
-60.65M 0.1%
ROC 12:
-11.93% 25.1%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise Mecbotamab vedotin, Ozuriftabmab vedotin, BA3071, and Bispecific antibody programs.
Finance Bot
Ask your questions
Start by typing a question below.
